Haleon, a prominent consumer health company, and Singapore’s Agency for Science, Technology and Research (A*STAR) have announced a new clinical study focusing on women’s metabolic health in Asia. The study, named the Impact of Multivitamin and Mineral Supplementation on Metabolic Health in Midlife Women (ISMOS), aims to generate evidence on the benefits of Centrum, a multivitamin and mineral supplement, for midlife Asian women—a demographic frequently underrepresented in global nutrition research.
The study is set to enhance understanding of preventive healthcare and healthy ageing within Asian populations. By focusing on metabolic health, the research seeks to provide insights into how supplements like Centrum can support women’s health during midlife, a critical period often associated with increased health risks.
Haleon and A*STAR’s collaboration highlights the importance of targeted research in addressing specific health needs. “This study will contribute significantly to the understanding of metabolic health in midlife women,” said a spokesperson from Haleon. The findings are expected to inform future healthcare strategies and supplement formulations tailored to the needs of Asian women.
As the study progresses, it may pave the way for more inclusive research in the field of women’s health, potentially influencing global health policies and practices. The results could lead to improved health outcomes for women in Asia and beyond, reinforcing the role of supplements in maintaining metabolic health.
